查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1926902

下肢動脈介入器材市場：2026-2032年全球預測（按器材類型、手術類型、應用和最終用戶分類）

Lower Limb Artery Interventional Devices Market by Device Type, Procedure Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，下肢動脈介入器材市場價值將達到 44.9 億美元，到 2026 年將成長至 47.5 億美元，到 2032 年將達到 69.3 億美元，複合年成長率為 6.39%。

關鍵市場統計數據
基準年 2025 44.9億美元
預計年份：2026年 47.5億美元
預測年份 2032 69.3億美元
複合年成長率 (%) 6.39%

在臨床創新、醫療實踐變革以及對可證實的衛生經濟價值的需求壓力下，闡明下肢動脈介入治療的現狀。

下肢動脈介入器材市場正處於人口老化、周邊動脈疾病盛行率上升以及手術技術快速創新交會的階段。旨在恢復和維持四肢血流的器械不僅是醫療技術，也是醫院和門診中心降低截肢率、提高病患生活品質的策略性資產。臨床、監管和商業相關人員需要在複雜的環境中權衡手術選擇、器械療效和經濟因素。

要認知到，設備技術的快速發展、臨床通訊協定的改進以及護理環境的轉變正在重塑手術決策和實施的動態。

由於技術進步、臨床通訊協定的不斷改進以及對最佳化治療環境的日益重視，下肢動脈介入治療領域正經歷變革性的變化。改良的動脈粥狀硬化斑塊切除術系統擴大了病變治療的範圍，能夠更精準地進行斑塊修整，並減少血管損傷。同時，球囊導管技術（尤其是藥物塗層球囊）持續影響著血管再阻塞的治療，促使臨床醫師重新評估以往在複雜股膕動脈疾病中優先考慮支架置入的決策流程。

評估2025年關稅環境如何促使供應鏈重組、採購流程審查以及重新關注國內製造業的韌性。

2025年美國關稅政策為依賴國際供應鏈的醫療設備製造商、經銷商和醫療服務提供者帶來了新的商業性複雜性。關稅相關的成本壓力迫使製造商重新評估其籌資策略，考慮將關鍵部件的生產轉移到近岸地區，並重新談判供應商契約，以在不影響質量或合規性的前提下維持單位經濟效益。這些調整對醫院系統和門診中心的庫存計劃和採購週期產生了連鎖反應，而這些機構歷來優先考慮的是最低庫存和可預測的前置作業時間。

分析諸如醫療設備類型、臨床環境、手術類型和解剖覆蓋範圍等細微細分因素，以發現差異化的策略重點。

從器械類型、最終用戶、手術類型和應用領域分析，市場呈現出明顯的異質性，每個維度都揭示了不同的策略意義。依器械類型分類，市場包括抽吸器械、斑塊動脈粥狀硬化斑塊切除術系統、球囊導管和支架系統。在抽吸器械中，手動和機械系統的普及路徑因手術複雜程度和吞吐量需求而異。動脈粥狀硬化斑塊切除術系統包括定向、雷射、軌道和旋轉技術，這些技術在病變適應性和資本密集度方面各不相同。球囊導管分為裸球囊和藥物釋放型球囊，會影響血管再阻塞的管理策略。支架系統還包括裸金屬支架和藥物釋放型支架，這代表了即時支撐和長期新生內膜控制之間的權衡。

確定區域支付方結構、監管差異和臨床偏好如何在全球範圍內塑造不同的採用路徑和商業模式。

區域趨勢對全球臨床實務模式和商業策略均有顯著影響。在美洲，支付方結構和醫院整合趨勢促使人們更加關注可驗證的臨床結果和成本效益，從而影響著大型醫院系統和不斷擴張的門診手術領域的產品採納。該地區的臨床醫生在做出採購決策時，往往傾向於採用循證工作流程和正式的衛生經濟學評估，這反過來又促使製造商透過可靠的真實世界數據和有針對性的培訓計畫來支持產品推廣。

了解創新、夥伴關係和基於證據的價值提案如何重新定義競爭定位和通往商業性成功的道路

主要參與者之間的競爭動態由產品創新、策略聯盟以及對實證醫學日益重視共同決定。現有市場參與者利用深厚的臨床關係和全面的手術產品組合來捍衛其市場佔有率，而新參與企業則往往在諸如新型動脈粥樣動脈粥狀硬化斑塊切除術機製或下一代藥物輸送技術等細分領域展開競爭。醫療設備製造商、診斷影像提供者和數位醫療供應商之間的策略聯盟正逐漸成為建立整合式手術解決方案的通用途徑，這些解決方案旨在應對臨床和工作流程方面的挑戰。

為製造商和供應商提供切實可行的策略，以協調創新重點、供應鏈韌性和證據生成，從而實現長期應用。

產業領導者應採取多管齊下的方法，將研發重點與具有臨床意義的成果結合，同時提升供應鏈透明度和商業性彈性。首先，應優先投資於能夠顯著降低再次手術率和手術併發症的技術，並確保臨床開發項目不僅涵蓋療效終點，還應涵蓋生活品質和衛生經濟學指標。這些數據對於與支付方和系統級採購方溝通至關重要，因為他們越來越需要長期價值的證明。

採用三角調查方法，結合專家訪談、醫療設備審核、監管審查和臨床證據綜合，得出可靠的研究結果。

本分析所依據的研究結合了定性專家訪談、醫療設備性能審核、監管路徑審查以及對臨床文獻和真實世界證據的系統評估。主要發現來自與介入醫師、採購負責人和臨床負責人的結構化討論，他們從操作觀點提供了關於器械性能、床邊決策因素和培訓需求的意見。器械性能審核了抽吸器械、動脈粥狀硬化斑塊切除術系統、球囊導管和支架系統之間的設計差異，以識別輸送性、器械特性以及與輔助性治療的兼容性方面的趨勢。

我們得出結論，以結果為導向的創新、供應鏈韌性以及與支付方一致的價值策略，對於確保持續的臨床和商業性成功至關重要。

總之，下肢動脈介入器材領域的特點是技術快速發展、臨床實踐經濟模式不斷變化，以及對可證實的臨床價值的需求日益成長。這些因素共同有利於致力於以結果為導向的創新、透明的價值鏈和快速商業化策略的製造商和醫療系統。隨著新型動脈粥狀硬化斑塊切除術機制、先進的藥物輸送球囊和不斷發展的支架技術被引入臨床實踐，能否將器械性能轉化為患者和醫療系統可衡量的獲益，將決定其能否被長期採用。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 下肢動脈介入器材市場（依器材類型分類）

  • 吸力裝置
    • 手動吸痰裝置
    • 機械吸力裝置
  • 動脈粥狀硬化斑塊切除術系統
    • 定向斑塊動脈粥狀硬化斑塊切除術
    • 雷射動脈動脈粥狀硬化斑塊切除術
    • 軌道動脈粥狀動脈粥狀硬化斑塊切除術
    • 旋切動脈粥狀硬化斑塊切除術
  • 球囊導管
    • 熊氣球
    • 藥物塗層球囊
  • 支架系統
    • 裸金屬支架
    • 藥物釋放型支架

9. 下肢動脈介入器材市場（依手術類型分類）

  • 動脈粥狀硬化斑塊切除術術
  • 經皮血管成形術
  • 支架置入術
  • 血栓切除術

第10章 下肢動脈介入器材市場（依應用領域分類）

  • 膝下介入治療
  • 股膕動脈介入治療
  • 膝下介入治療

第11章 下肢動脈介入器材市場（依最終用戶分類）

  • 門診手術中心
  • 醫院
  • 專科診所

第12章 下肢動脈介入器材市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 下肢動脈介入器材市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國下肢動脈介入器材市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

15. 美國下肢介入器材市場

第16章：中國下肢動脈介入器材市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cook Medical LLC
  • Johnson & Johnson
  • Koninklijke Philips NV
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Terumo Corporation
  • WL Gore & Associates, Inc.
Product Code: MRR-4F7A6D4FF369

The Lower Limb Artery Interventional Devices Market was valued at USD 4.49 billion in 2025 and is projected to grow to USD 4.75 billion in 2026, with a CAGR of 6.39%, reaching USD 6.93 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.49 billion
Estimated Year [2026] USD 4.75 billion
Forecast Year [2032] USD 6.93 billion
CAGR (%) 6.39%

Clarifying the modern lower limb artery interventional landscape amid clinical innovation, care site shifts, and pressure for demonstrable health-economic value

The lower limb artery interventional devices landscape sits at the intersection of aging demographics, rising prevalence of peripheral arterial disease, and accelerating procedural innovation. Devices designed to restore and preserve limb perfusion are not only medical technologies but also strategic assets for hospitals and outpatient centers seeking to reduce amputation rates and improve patient quality of life. Stakeholders across clinical, regulatory, and commercial functions are navigating a complex environment where procedural choice, device efficacy, and economic considerations converge.

Recent advances in device materials, imaging guidance, and combination therapies have expanded treatment options across the care continuum. As a result, clinicians are increasingly equipped to tailor interventions-ranging from minimally invasive thrombectomy to targeted atherectomy and drug-delivery strategies-based on lesion morphology and patient comorbidity. Transitioning care into ambulatory surgical centers and specialty clinics has intensified competition among device manufacturers, creating pressure to demonstrate clear clinical differentiation and health-economic benefit. In this context, the industry must balance procedural innovation with evidence generation and scalable commercial models.

Recognizing rapid evolution in device technology, clinical protocols, and care-site migration that are reshaping procedural decision-making and adoption dynamics

The landscape for lower limb artery interventions is undergoing transformative shifts driven by technological refinement, evolving clinical protocols, and a growing emphasis on care-site optimization. Improvements in atherectomy systems have expanded lesion treatability, enabling more precise plaque modification while limiting vessel trauma. Concurrently, balloon catheter technology-particularly drug-coated platforms-continues to influence restenosis management, prompting clinicians to reassess decision trees that previously favored stenting in complex femoropopliteal disease.

Beyond device evolution, the procedural ecosystem is changing. There is an observable migration of straightforward endovascular cases from inpatient hospital settings to ambulatory surgical centers and specialty clinics, where workflow efficiency and cost structure differ markedly. This migration drives demand for devices that combine procedural simplicity with predictable outcomes. Moreover, integration of imaging advances, digital procedural planning, and adjunctive pharmacotherapies is reshaping clinical guidelines and institutional protocols. As a result, manufacturers must not only innovate in product design but also invest in outcomes data and pathway optimization to secure adoption in increasingly cost-sensitive and outcome-oriented care environments.

Assessing how the 2025 tariff environment catalyzed supply chain reconfiguration, procurement scrutiny, and renewed focus on domestic manufacturing resilience

The imposition of tariffs by the United States in 2025 introduced a new dimension of commercial complexity for device manufacturers, distributors, and healthcare providers that rely on transnational supply chains. Tariff-related cost pressures have prompted manufacturers to reassess sourcing strategies, consider nearshoring critical component production, and renegotiate supplier contracts to preserve unit economics without compromising quality or regulatory compliance. These adjustments have had cascading effects on inventory planning and procurement cycles within hospital systems and ambulatory centers that traditionally prioritized lean inventories and predictable lead times.

In practice, organizations facing higher import costs have increased scrutiny of device total cost of ownership, placing renewed emphasis on clinical durability and reintervention rates as measures of value. Payers and procurement teams are responding by tightening contracting terms and seeking structured evidence of downstream savings. Consequently, the tariff environment has elevated the importance of supply chain transparency, dual-source strategies, and investment in domestic manufacturing capacity where feasible. Over time, this environment incentivizes integrated commercial models that align manufacturing footprint with reimbursement realities and clinical performance data, thereby mitigating margin erosion and preserving access to advanced therapies.

Unpacking nuanced segmentation across device types, care settings, procedural classes, and anatomical applications to reveal differentiated strategic priorities

The market demonstrates clear heterogeneity when parsed by device type, end user, procedure type, and application, each dimension revealing distinct strategic implications. Based on device type, the landscape spans aspiration devices, atherectomy systems, balloon catheters, and stent systems; within aspiration devices, manual and mechanical modalities exhibit different adoption curves driven by procedural complexity and throughput needs; atherectomy systems encompass directional, laser, orbital, and rotational technologies that vary in lesion suitability and capital intensity; balloon catheters bifurcate into bare balloon and drug-coated balloon options that influence restenosis management strategies; and stent systems include both bare metal and drug-eluting stents that represent trade-offs between immediate scaffolding and long-term neointimal control.

When considering end users, ambulatory surgical centers, hospitals, and specialty clinics present distinct purchasing behaviors, capital constraints, and procedural volumes that influence product preference and contractual arrangements. Procedure type further nuances the landscape, with atherectomy procedures, percutaneous transluminal angioplasty, stenting procedures, and thrombectomy procedures each requiring tailored device features, operator training, and adjunctive support. Finally, application-level segmentation-below the knee intervention, femoropopliteal intervention, and infrapopliteal intervention-dictates device design priorities such as flexibility, deliverability, and drug-delivery kinetics. Taken together, these segmentation lenses underscore the necessity for manufacturers to develop modular strategies that align product portfolios with specific clinical workflows and purchasing frameworks.

Identifying how regional payer structures, regulatory diversity, and clinical preferences shape differentiated adoption pathways and commercial models globally

Regional dynamics strongly influence both clinical practice patterns and commercial strategies across the global landscape. In the Americas, payer structures and hospital consolidation trends drive emphasis on demonstrable clinical outcomes and cost-effectiveness, shaping adoption in both large hospital systems and an expanding ambulatory surgery segment. Clinicians in this region often favor evidence-based workflows and formal health-economic assessments when making procurement decisions, which in turn encourages manufacturers to support product adoption with robust real-world data and targeted training programs.

In Europe, Middle East & Africa, diverse reimbursement models and regulatory environments create a patchwork of adoption pathways where market entry often requires localized evidence generation and agile distribution strategies. Meanwhile, Asia-Pacific presents a varied picture characterized by rapid technology uptake in certain urban centers alongside cost-sensitive markets that prioritize procedural affordability and supply chain efficiency. Across all regions, cross-border regulatory harmonization efforts, capacity-building initiatives, and localized clinical education remain central to expanding access and aligning product development with regional clinical needs. Consequently, commercial plans must be regionally tailored, balancing scale economics with local clinical and regulatory realities.

Explaining how innovation, partnerships, and evidence-based value propositions are redefining competitive positioning and pathways to commercial success

Competitive dynamics among leading players are defined by a mix of product innovation, strategic partnerships, and an increasing emphasis on evidence generation. Market incumbents leverage deep clinical relationships and comprehensive procedural portfolios to defend share, while newer entrants often compete on niche differentiation such as novel atherectomy mechanisms or next-generation drug-delivery technologies. Strategic collaborations between device firms, imaging providers, and digital health vendors are emerging as a common route to create integrated procedural solutions that address both clinical and workflow challenges.

Beyond product features, companies are investing in outcome-focused value propositions that align with hospital quality metrics and payer priorities. This includes expanded registries, sponsored investigator-initiated trials, and health-economic modeling to quantify the downstream impact of reduced reintervention and limb-salvage rates. Additionally, M&A and alliance activity remains a viable pathway to access complementary technologies or to accelerate geographic expansion. For companies seeking to compete, the combination of clinical evidence, supply chain reliability, and post-market support increasingly determines whether a technology achieves sustained clinical integration and commercial traction.

Presenting actionable strategies for manufacturers and providers to align innovation priorities, supply chain resilience, and evidence generation for long-term adoption

Industry leaders should take a multi-pronged approach that aligns R&D priorities with clinically meaningful outcomes, while simultaneously strengthening supply chain transparency and commercial agility. First, prioritize investments in technologies that demonstrably reduce reintervention rates and procedural complications, and ensure that clinical development programs capture not only efficacy endpoints but also quality-of-life and health-economic measures. These data will be pivotal when engaging payers and system-level purchasers who increasingly require proof of long-term value.

Second, diversify supply chains and invest in dual-source or regional manufacturing capabilities to mitigate tariff and import-risk exposure. This structural resilience should be paired with flexible commercial models that accommodate the procurement preferences of hospitals, ambulatory centers, and specialty clinics. Third, cultivate integrated solutions through partnerships with imaging and digital health providers to streamline workflows and reduce procedural variability. Finally, expand training and post-market surveillance programs to accelerate safe adoption in new care settings and to generate real-world evidence that supports reimbursement negotiations and guideline inclusion.

Describing a triangulated research methodology combining expert interviews, device audits, regulatory reviews, and clinical evidence synthesis for robust insights

The research underpinning this analysis combined qualitative expert interviews, device feature audits, regulatory pathway reviews, and a systematic assessment of clinical literature and real-world evidence. Primary insight was derived from structured discussions with interventionalists, procurement officers, and clinical leaders who shared operational perspectives on device performance, care-site decision drivers, and training requirements. Device feature audits examined design differentiation across aspiration devices, atherectomy systems, balloon catheters, and stent systems to identify trends in deliverability, device profile, and adjunctive therapy compatibility.

Complementing primary research, regulatory pathway reviews and clinical literature syntheses provided context on approval trends, labeling updates, and emergent clinical consensus. Real-world evidence registries and published post-market surveillance studies were evaluated to understand safety and durability signals across key applications such as below the knee, femoropopliteal, and infrapopliteal interventions. Throughout the methodology, findings were triangulated to ensure that commercial and clinical interpretations reflect a balanced view of innovation, procedural adoption, and system-level constraints.

Summarizing the imperative for outcome-driven innovation, supply chain resilience, and payer-aligned value strategies to secure enduring clinical and commercial success

In conclusion, the lower limb artery interventional devices arena is defined by accelerating technological refinement, shifting care-site economics, and heightened demands for demonstrable clinical value. These forces collectively favor manufacturers and health systems that commit to outcome-oriented innovation, transparent supply chains, and responsive commercialization strategies. As clinical practice integrates newer atherectomy mechanisms, advanced drug-delivery balloons, and evolving stent technologies, the ability to translate device performance into measurable patient and system benefits will determine long-term adoption.

Looking ahead, stakeholders who invest in rigorous evidence generation, regional market tailoring, and adaptive operational models will be best positioned to capture opportunity while navigating policy and procurement headwinds. The imperative for coordinated efforts-linking clinical evidence, manufacturing resilience, and payer-aligned value propositions-has never been greater, and organizations that act decisively will more effectively drive improved limb salvage outcomes and durable commercial returns.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Lower Limb Artery Interventional Devices Market, by Device Type

  • 8.1. Aspiration Devices
    • 8.1.1. Manual Aspiration
    • 8.1.2. Mechanical Aspiration
  • 8.2. Atherectomy Systems
    • 8.2.1. Directional Atherectomy
    • 8.2.2. Laser Atherectomy
    • 8.2.3. Orbital Atherectomy
    • 8.2.4. Rotational Atherectomy
  • 8.3. Balloon Catheters
    • 8.3.1. Bare Balloon
    • 8.3.2. Drug-Coated Balloon
  • 8.4. Stent Systems
    • 8.4.1. Bare Metal Stent
    • 8.4.2. Drug-Eluting Stent

9. Lower Limb Artery Interventional Devices Market, by Procedure Type

  • 9.1. Atherectomy Procedures
  • 9.2. Percutaneous Transluminal Angioplasty
  • 9.3. Stenting Procedures
  • 9.4. Thrombectomy Procedures

10. Lower Limb Artery Interventional Devices Market, by Application

  • 10.1. Below The Knee Intervention
  • 10.2. Femoropopliteal Intervention
  • 10.3. Infrapopliteal Intervention

11. Lower Limb Artery Interventional Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Lower Limb Artery Interventional Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Lower Limb Artery Interventional Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Lower Limb Artery Interventional Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Lower Limb Artery Interventional Devices Market

16. China Lower Limb Artery Interventional Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. B. Braun Melsungen AG
  • 17.7. Becton, Dickinson and Company
  • 17.8. Boston Scientific Corporation
  • 17.9. Cook Medical LLC
  • 17.10. Johnson & Johnson
  • 17.11. Koninklijke Philips N.V.
  • 17.12. Medtronic plc
  • 17.13. MicroPort Scientific Corporation
  • 17.14. Terumo Corporation
  • 17.15. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY MANUAL ASPIRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY MANUAL ASPIRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY MANUAL ASPIRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY MECHANICAL ASPIRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY MECHANICAL ASPIRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY MECHANICAL ASPIRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY LASER ATHERECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY LASER ATHERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY LASER ATHERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ORBITAL ATHERECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ORBITAL ATHERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ORBITAL ATHERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ROTATIONAL ATHERECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ROTATIONAL ATHERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ROTATIONAL ATHERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BARE BALLOON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BARE BALLOON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BARE BALLOON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG-COATED BALLOON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG-COATED BALLOON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG-COATED BALLOON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BARE METAL STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BARE METAL STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BARE METAL STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG-ELUTING STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG-ELUTING STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG-ELUTING STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENTING PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENTING PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENTING PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY THROMBECTOMY PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY THROMBECTOMY PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY THROMBECTOMY PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BELOW THE KNEE INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BELOW THE KNEE INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BELOW THE KNEE INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY FEMOROPOPLITEAL INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY FEMOROPOPLITEAL INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY FEMOROPOPLITEAL INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY INFRAPOPLITEAL INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY INFRAPOPLITEAL INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY INFRAPOPLITEAL INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. GCC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GCC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. GCC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 168. GCC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 169. GCC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 170. GCC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 171. GCC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. GCC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. GCC LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. G7 LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. G7 LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. G7 LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 195. G7 LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 196. G7 LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 197. G7 LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 198. G7 LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. G7 LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. G7 LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. NATO LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. NATO LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. NATO LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 204. NATO LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 205. NATO LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 206. NATO LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 207. NATO LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. NATO LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. NATO LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ASPIRATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA LOWER LIMB ARTERY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)